Home
Resources
Publications
Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients With Psoriasis

Individual Burden of Psoriasis (I-BOP): Building and Validation of a New Scoring Tool for Patients With Psoriasis

Khaled Ezzedine, Anne Claire Fougerousse, Roberte Aubert, Jean-Benoît Monfort, Ziad Reguiaï, Jason Shourick, Charles Taieb, François Maccari

Clin Cosmet Investig Dermatol. 2020 May 4;13:325-332.

PMID: 32440185

Abstract:

Background:
Psoriasis impacts independently of its severity on patients' lifestyle and quality of life (QoL).
Aim:
To build a tool for assessing the patient-reported psoriasis burden.
Methods:
An expert group created a questionnaire using a standardized methodology building questionnaires assessing quality of life issues. The questionnaire was translated from French into a cultural and linguistically validated US English version.
Results:
A conceptual questionnaire of 54 questions was created. The confirmatory analyses resulted in a 10-feature questionnaire divided into 4 internally consistent domains with a Cronbach's alpha coefficient of 0.9. It was reproducible and highly reliable. It correlated well with the Dermatology Life Quality Index (DLQI), Perceived Stress Scale (PSS), and SF-12 mental and SF12 physical scores.
Conclusion:
This tool allows for the first time to assess the burden of psoriasis patients. Its use may allow improving medical and nonmedical patient care, thus improving their daily life.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP128719904	I-BOP		128719-90-4	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: